Discussion :  

This roundtable will explore how oncology clinical teams identify patient-level retention and execution risk, where current signals may surface too late, and what types of data or indicators could provide earlier visibility. The discussion will also examine what would make a predictive retention signal useful and actionable in real-world trial operations, and where earlier intervention could have the greatest impact.